Medical Innovation Exchange

Takeda, Arrowhead hit one target for rare disease drug, but placebo overperformance sends biotech's shares tumbling

https://www.fiercebiotech.com/biotech/takeda-arrowhead-hit-one-target-rare-disease-drug-placebo-overperformance-sends-biotechs

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!